Pulmonary Vascular Disease

New evidence-based guidelines from the American College of Chest Physicians (ACCP) recommend considering individual patients’ risk of thrombosis when deciding for or against the use of preventive therapies for deep vein thrombosis (DVT) and venous thromboembolism (VTE). Specifically, the Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, published in the February issue of the journal CHEST, focus on risk stratification of patients, suggesting clinicians should consider a patient’s risk for DVT/VTE and risk for bleeding before administering or prescribing a prevention therapy.

CHEST 2011
Morning Educational Symposium
Preparing for the New Anticoagulants

August 22-26, 2012, Phoenix, AZ

October 20-25, 2012, Atlanta, GA

Dr. King speaks on Anticoagulation and Thrombolysis Strategies in Patients With Massive PE

Two large waves of pandemic influenza A(H1N1) have swept across the country, and now viral respiratory disease experts are assessing what the health care community did right—and wrong—to improve response should a third wave hit.

Have you been waiting for the ACCP-SEEK app to include pulmonary and critical care questions? Well, the new version is now available in iTunes and contains 400 more questions!